Northwest Biotherapeutics, Inc. is a biotechnology company. The Company is focused on developing personalized immune therapies for cancer. It has developed a platform technology, DCVax, which uses activated dendritic cells to mobilize a patient's own... Read more
MarketWatch
CNBC
CNBC
Yahoo
Access detailed stock analysis from LSEG including analyst price target estimates.